Printed From BioPortfolio.com
Bristol-Myers Q4 Results Top View; Meets Primary Endpoint In Lung Cancer Trail
08:10 EST 5 Feb 2018 | FinanzNachrichten
NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Co. (BMY) Monday posted loss for the fourth-quarter 2017, compared to profit in the prior year, reflecting impact from U.S. tax reform. Both adjusted...
Original Article: Bristol-Myers Q4 Results Top View; Meets Primary Endpoint In Lung Cancer Trail
